Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03090932 · ClinicalTrials.gov registry record
Longitudinal Study of Innate Lymphoid Cells in Peripheral Blood in ALS
A clinical trial, sponsored by University of Michigan.
- Terminated
- Registry status
- 66
- Enrollment target
NCT03090932 is a clinical trial that was terminated before completion, run by University of Michigan. The registered enrollment target is 66 participants.
The verdict
NCT03090932 was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- 66 participants
- Enrollment target
Study Summary
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder characterized by progressive muscle weakness and eventual death. Studies demonstrate that the immune system plays a key role in ALS progression; however, the role of the immune system is unclear, as various aspects can play both a beneficial and detrimental role in the disease course. Attempts to universally suppress the immune system in ALS patients have at best had negligible effects on progression or at worst accelerated the disease. Thus, there is a critical need to identify immune cell populations to serve as biomarkers and therapeutic targets.
Interventions
- OTHER Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2016-01-18 |
| Est. Completion | 2020-11-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03090932
The ClinicalTrials.gov registry entry for NCT03090932 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.
NCT03090932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03090932 about?
NCT03090932 is a clinical study titled "Longitudinal Study of Innate Lymphoid Cells in Peripheral Blood in ALS". Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder characterized by progressive muscle weakness and eventual death. Studies demonstrate that the immune system plays a key role in ALS progression; however, the role of the immune system is unclear, as various aspects can p...
What is the current status of trial NCT03090932?
This trial is currently terminated. The enrollment target is 66 participants. The study started on 2016-01-18. Estimated completion is 2020-11-13.
What interventions are being tested in trial NCT03090932?
The interventions under investigation include: Blood draw (OTHER).
Who is sponsoring clinical trial NCT03090932?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.